Treatment Action Group releases policy brief on US investments in tuberculosis research and development: A policy brief released by TAG today argues that decreasing US investment in TB research adds to the public health threat posed by TB to the United States and has already stalled the development of better and faster-acting treatment. Thanks to stagnant […]
The following is a guest post by Madhukar Pai of the McGill International TB Centre, Prashant Yadav of Montreal & Stephen M. Ross School of Business, and Ravi Anupindi of the University of Michigan, Ann Arbor. Whether it is mobile phone service or vacation travel, good businesses know that success depends on providing a complete and customer-centric solution. Should patients with tuberculosis […]
HIV
The tale of two global HIV responses continues to unfold this week, in data released by UNAIDS in the run-up to the 22nd International AIDS Conference […]
Tuberculosis
New, more effective medicines replace painful, daily shots, drugs causing psychosis, permanent hearing loss; TB and medical communities welcome change, say recommended drugs must be accessible, affordable […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
The following is a guest post by By Jackie Hellen, MPH of MEASURE Evaluation Community workers and program managers work tirelessly to control HIV at the local […]